How urine copper changes over 24 hours in Wilson disease
Part of Brain & nervous system, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how copper levels in urine change throughout the day and night in people with Wilson disease. If you take part, you will collect all your urine for 24 hours so researchers can measure copper at different times.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Wilson disease (a Leipzig score greater than 4).
- You must be between 6 and 70 years old.
- You must be able to collect your urine over 24 hours.
- You must currently be taking D-Penicillamine, Trientine, or Zinc for your Wilson disease.
- Your medication must not have changed in the last 6 months before joining the study.
- You cannot have had a liver transplant or have severe chronic kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at what happens to copper levels in the urine when people with Wilson disease briefly stop their medicine. It may help doctors understand how well your body controls copper without treatment.
This study looks at how Wilson's disease affects the kidneys. It aims to better understand kidney problems in people with Wilson's disease, which could help improve care.
This trial is for people who already have a genetic diagnosis of Wilson disease. It looks at whether specific lab tests and a physical eye finding can help confirm and support the diagnosis.
This study follows people who already have Wilson disease to understand how the condition changes over time. It may help researchers better predict future symptoms and improve care.
This trial uses a special PET scan with a copper tracer to see how well gene therapy is working in people with Wilson disease. It may help doctors understand if the treatment is helping your body handle copper properly.
This study tests an injection called LY-M003 for people with Wilson disease who have already been treated with standard medicines. The goal is to see if it is safe and works for them.
Hear when a new Wilson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.